References
1. Lazowska-Przeorek I, Kakol D, Karolewska-Bochenek K, Banaszkiewicz A. “Cobblestone” Appearance of Esophagus: An Unusual Symptom of Pyloric Stenosis. Journal of Pediatric Gastroenterology and Nutrition. 2017;65(5):e110.
2. Zimmer V, Emrich K. Cobblestone esophagus in eosinophilic esophagitis. Advances in Digestive Medicine. 2023;10(1):58-9.
3. Jang KM, Lee KS, Lee SJ, Kim EA, Kim TS, Han D, Shim YM. The spectrum of benign esophageal lesions: imaging findings. Korean J Radiol. 2002;3(3):199-210.
4. Yang GD, Lu PX, Qin J, Liu ST, Zhan NY. Radiologic diagnosis for AIDS patients complicated with candidal esophagitis. Chin Med J (Engl). 2011;124(7):965-7.
5. De Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, et al. Esophagitis Associated with the Use of Alendronate. New England Journal of Medicine. 1996;335(14):1016-21.
6. Yamamoto K, Kishino M, Nakamura S, Tokushige K. Symptoms and Upper Gastrointestinal Mucosal Injury Associated with Bisphosphonate Therapy. Intern Med. 2019;58(8):1049-56.
7. Abdi S, Masbough F, Nazari M, Abbasinazari M. Drug-induced esophagitis and helpful management for healthcare providers. Gastroenterol Hepatol Bed Bench. 2022;15(3):219-24.
8. Goldberg HI, Dodds WJ. Cobblestone esophagus due to Monilial infection. Am J Roentgenol Radium Ther Nucl Med. 1968;104(3):608-12.
9. Kim SH, Jeong JB, Kim JW, Koh SJ, Kim BG, Lee KL, et al. Clinical and endoscopic characteristics of drug-induced esophagitis. World J Gastroenterol. 2014;20(31):10994-9.
10. Cryer B, Bauer DC, editors. Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clinic Proceedings; 2002: Elsevier.